COVID-19 Vaccines and Children – an Important Conversation
Health Canada has approved the Pfizer/BioNTech COMIRNATY® mRNA vaccine for children ages five to 11. (This vaccine uses Acuitas Therapeutics’ lipid nanoparticle delivery system.) All vaccines approved for use in Canada undergo a strict testing, review and approval process. The Government
New Acuitas Therapeutics Video
Acuitas Therapeutics partners with pharmaceutical companies, biotechnology companies and academic institutes to advance nucleic acid therapeutics to the clinic and to the marketplace. After more than a decade of work on our lipid nanoparticle delivery system, it now plays a
What You Need to Know About COVID-19 Vaccines for Children
The Pfizer/BioNTech COVID-19 vaccine COMIRNATY® has received Health Canada’s approval for children ages five to 11. (Acuitas provides the lipid nanoparticle delivery system for this mRNA vaccine.) In a CBC article, which is in a useful Q&A format, a spokesperson for